| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.19 | 0.004 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.004 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |